Table 3.

Change in Mean Copy Number Over Time for cfxA and vanRD in Placebo vs Ribaxamase-Treated Patients

Treatment Group	T0	T1	T2
cfxA
Placebo	169,373a ±24,137b	279,822 ±58,886	237,738 ±70,114
Ribaxamase	237,012 ±40,149	118,367 ±35,227	150,350 ±46,667
vanRD
Placebo	51 ±34	152 ±63	66 ±31
Ribaxamase	69 ±49	25 ±45	95 ±82

Notes: ^aMean copy number. ^bStandard error.